Acute injury protocols typically run 4 to 6 weeks with a subsequent 2 to 4 week break before reassessment
Regardless of your perspective on peptide therapy, this represents one of the most significant regulatory developments in the peptide space in recent years
In Europe and the US, prescribed medications rank as the third leading cause of death right after heart disease and cancer, with approximately half of these deaths due to taking the medication correctly as prescribed, while the other half of these deaths are due to overdoses or drug abuse (274, 279)
Then save it to My Stuff
Reclassification is not supposed to be a route for unapproved drugs to get into the market, Janet Woodcock, a former FDA chief deputy commissioner who helped oversee the 2023 assignment of the peptides to category two due to safety concerns, told ProPublica before the meeting
No, BPC-157 is not FDA-approved